πŸ‡ΊπŸ‡Έ FDA
Patent

US 12134609

Quinoline cGAS antagonist compounds

granted A61PA61P25/28A61P29/00

Quick answer

US patent 12134609 (Quinoline cGAS antagonist compounds) held by The Board of Regents of the University of Texas System expires Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Nov 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61P, A61P25/28, A61P29/00